Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis
Authors
Keywords
Metastatic breast cancer, Ki-67, Progesterone receptor, Proliferation, Prognosis
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 138, Issue 3, Pages 899-908
Publisher
Springer Nature
Online
2013-03-11
DOI
10.1007/s10549-013-2460-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer
- (2012) Elisabetta Munzone et al. BREAST CANCER RESEARCH AND TREATMENT
- Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer
- (2012) Katharina Heusinger et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases
- (2012) Laurien D. C. Hoefnagel et al. CANCER
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
- (2011) Peter A Fasching et al. BMC CANCER
- Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
- (2011) Quinci Romero et al. BMC CANCER
- Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition
- (2011) Masakazu Toi et al. CANCER SCIENCE
- HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care
- (2011) A. Fabi et al. CLINICAL CANCER RESEARCH
- ZNF703is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium
- (2011) Daniel G. Holland et al. EMBO Molecular Medicine
- ZNF703gene amplification at 8p12 specifies luminal B breast cancer
- (2011) Fabrice Sircoulomb et al. EMBO Molecular Medicine
- St.-Gallen-Konferenz 2011 zum primären Mammakarzinom
- (2011) M. Untch et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Mammakarzinom 2011 – Neue Aspekte
- (2011) S. Kümmel et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- The biology of progesterone receptor in the normal mammary gland and in breast cancer
- (2011) Alison E. Obr et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss
- (2011) Giuseppe Bogina et al. VIRCHOWS ARCHIV
- Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
- (2011) Reiki Nishimura et al. World Journal of Surgical Oncology
- HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
- (2010) Ulla Wilking et al. BREAST CANCER RESEARCH AND TREATMENT
- Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register
- (2010) Javier Puente et al. BREAST CANCER RESEARCH AND TREATMENT
- Stability of estrogen receptor status in breast carcinoma
- (2010) Yun Gong et al. CANCER
- Neue Konzepte in der zielgerichteten systemischen Therapie des Mammakarzinoms
- (2010) C. Liedtke et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Aktuelle Therapie der Patientin mit einem Mammakarzinom
- (2010) P. Fasching et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial
- (2010) Andre Mattar et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
- (2010) Abigail S. Caudle et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Prognostic factors in 1038 women with metastatic breast cancer
- (2008) R. Largillier et al. ANNALS OF ONCOLOGY
- The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
- (2008) Robin L. Jones et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started